Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,726 | -18,898 | -28,643 | -24,850 | -10,833 |
| Depreciation Amortization | 48 | 102 | 30 | 20 | 9 |
| Other Working Capital | 4,048 | -2,900 | 767 | 2,593 | 2,729 |
| Other Operating Activity | 4,788 | 2,880 | 3,077 | 2,108 | -494 |
| Operating Cash Flow | $-27,842 | $-18,816 | $-24,769 | $-20,129 | $-8,589 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,000 | -20,970 | 2,040 | -5,962 | N/A |
| PPE Investments | -83 | -450 | -644 | -352 | -33 |
| Investing Cash Flow | $19,917 | $-21,420 | $1,396 | $-6,314 | $-33 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 193 | N/A | N/A | 6,975 |
| Common Stock Issued | 42,314 | 52,643 | -43 | 167 | 41,330 |
| Other Financing Activity | -193 | -5,247 | -2,128 | 28,278 | 0 |
| Financing Cash Flow | $42,121 | $47,589 | $-2,171 | $28,445 | $48,305 |
| Beginning Cash Position | 33,531 | 26,178 | 51,722 | 49,720 | 10,037 |
| End Cash Position | 67,727 | 33,531 | 26,178 | 51,722 | 49,720 |
| Net Cash Flow | $34,196 | $7,353 | $-25,544 | $2,002 | $39,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,842 | -18,816 | -24,769 | -20,129 | -8,589 |
| Capital Expenditure | -83 | -450 | -644 | -352 | -33 |
| Free Cash Flow | -27,925 | -19,266 | -25,413 | -20,481 | -8,622 |